Japan Dialysis Market

Plastic Optic Fiber Market Report Thumbnail

Japan Dialysis Market by Dialysis Type (Hemodialysis and Peritoneal Dialysis), Products & Services (Equipment, Consumables, Drugs, and Services), End User (In-center Dialysis, and Home Dialysis) – Global Opportunity Analysis and Industry Forecast, 2024–2030

Industry: Healthcare | Publish Date: 06-Dec-2024 | No of Pages: 101 | No. of Tables: 71 | No. of Figures: 36 | Format: PDF | Report Code : HC1270

  • Facebook
  • Linkedin
  • Whatsapp

Market Overview:

The Japan Dialysis Market size was valued at USD 2.86 billion in 2023, and is expected to reach USD 3.89 billion by 2030, with a CAGR of 4.5% from 2024 to 2030.

Japan dialysis market is a segment of the healthcare sector focused on providing artificial kidney functions to individuals with impaired renal function. Dialysis is a life-sustaining medical procedure used to manage patients with end-stage renal disease (ESRD) or acute kidney injuries.

This market includes various products and services such as hemodialysis and peritoneal dialysis equipment, dialysis consumables, and associated pharmaceuticals. Given the growing prevalence of kidney-related disorders and the increasing aging population, the market is crucial in delivering essential renal care, aiming to enhance patients' quality of life and improve overall healthcare outcomes.

Increasing Healthcare Expenditure and Investments Drives the Market Expansion

The escalating healthcare expenditure is a pivotal driver for the Japan dialysis market, fostering increased investments in renal care infrastructure. As countries allocate substantial resources to enhance their healthcare systems, the expansion of dialysis services becomes a focal point.

This augmented financial commitment translates into improved accessibility to dialysis facilities, upgraded medical equipment, and enhanced patient care. The growing healthcare expenditure underscores a collective effort to address the rising prevalence of kidney-related ailments, further propelling the demand for dialysis treatments and positively impacting the overall market dynamics.

 

Spike in the Cases of Diabetes and Hypertension Propels the Market Growth:

The surge in diabetes and hypertension cases in the country contributes significantly to the growth of the market. These chronic conditions, especially when unmanaged, can lead to kidney damage and eventually chronic kidney disease (CKD). 

With the increasing prevalence of diabetes and hypertension, there is a corresponding rise in the incidence of CKD, necessitating the use of dialysis as a crucial therapeutic intervention. The expanding patient pool with these comorbidities underscores the importance of dialysis services in managing kidney-related complications, driving the demand for dialysis treatments.

Risk associated with Infection and Complications, Hinders the Market Expansion

One of the significant challenges in Japan dialysis market is the inherent risk of infections and complications associated with these procedures. Gap in adherence to stringent hygiene practices and inadequate sterilization measures can elevate the effect of infections, posing a threat to patient health. Additionally, complications arising from the dialysis process itself can contribute to treatment challenges.

 

The Introduction of Wearable and Portable Dialysis Devices Creates Future Opportunity for the Market

The emergence of wearable and portable dialysis devices stands as a groundbreaking advancement in dialysis technology, offering a transformative opportunity for the dialysis market. These compact systems, resembling small backpacks, empower patients with unprecedented mobility and flexibility in their treatment schedules.

For instance, AWAK Technologies (AWAK), an innovative medical technology firm specializing in dialysis using regenerative technology for end-stage renal disease, revealed that the U.S. Food and Drug Administration (FDA) conferred the breakthrough device designation upon its AWAK Peritoneal Dialysis (AWAK PD) device.

This device, which is both wearable and highly portable, incorporates AWAK's patented sorbent technology. As technology continues to advance, we can anticipate further innovations in dialysis technology, ultimately leading to even better outcomes for patients.

 

Competitive Landscape 

Several market players operating in the Japan dialysis market include Baxter International, Inc., DaVita Inc., Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, Medicators, Inc, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH, and others.

Japan Dialysis Market Key Segments

By Dialysis Type

  • Hemo Dialysis

  • Peritoneal Dialysis

By Products & Services

  • Equipment

  • Consumables

  • Drugs

  • Services

By End User

  • In-center Dialysis

  • Home Dialysis

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Market Size in 2023

USD 2.86 Billion

Revenue Forecast in 2030

USD 3.89 Billion

Growth Rate

CAGR of 4.5% from 2024 to 2030

Analysis Period

2023–2030

Base Year Considered

2023

Forecast Period

2024–2030

Market Size Estimation

Billion (USD)

Growth Factors

  • Rising Diabetes and Hypertension Cases

  • Rising Healthcare Expenditure and Investments by the Government

Companies Profiled

10

Market Share

Available for 10 companies

Customization Scope

Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs.

KEY PLAYERS

  • Baxter International, Inc.

  • DaVita Inc.

  • Nikkiso Co. Ltd.

  • NxStage Medical, Inc.

  • Asahi Kasei Corporation

  • Medicators, Inc.

  • Fresenius Medical Care AG & Co. KGaA

  • Nipro Corporation

  • B. Braun Avitum AG

  • Diaverum Deutschland GmbH

Bar chart Pie chart Pie chart

Frequently Asked Questions

The leading companies in Japan dialysis market include Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., DaVita Inc., Nipro Corporation, B. Braun Melsungen AG, and others.

According to projections from Next Move Strategy Consulting, the Japan dialysis market is anticipated to reach USD 3.89 billion by 2030.

The significant challenges in the Japan dialysis market is the risk attached to infection and complication.

Japan dialysis market is segmented on the basis of dialysis type, products and services, and end-user.

The Japan dialysis market was valued at USD 2.86 billion in 2023, as per the findings of Next Move Strategy Consulting's report.

Download Free Sample

Please Enter Full Name

Please Enter Valid Email ID

Please enter Country Code and Phone No

Please enter message

popular
$2,575
$1,575
$3,875
$2,975

This website uses cookies to ensure you get the best experience on our website. Learn more